Your browser doesn't support javascript.
loading
Correlation analysis between BRAFV600E mutation and ultrasonic and clinical features of papillary thyroid cancer.
Wen, Jiahao; Liu, Haizhou; Lin, Yanyan; Liang, Zixuan; Wei, Lili; Zeng, Qi; Wei, Shanshan; Zhang, Litu; Yang, Weiping.
Afiliação
  • Wen J; Department of Ultrasound, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Liu H; Department of Research, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Lin Y; Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Liang Z; Department of Research, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Wei L; Department of Ultrasound, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Zeng Q; Department of Ultrasound, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Wei S; Department of Ultrasound, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Zhang L; Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
  • Yang W; Department of Research, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
Heliyon ; 10(9): e29955, 2024 May 15.
Article em En | MEDLINE | ID: mdl-38726195
ABSTRACT

Purpose:

The study investigates the value of the BRAFV600E mutation in determining the aggressiveness of papillary thyroid cancer (PTC) and its correlation with ultrasound features.

Methods:

The study selected 176 patients with BRAFV600E mutation and 80 without the mutation who underwent surgery at Guangxi Medical University Cancer Hospital. Clinical and pathological data were collected, focusing on BRAFV600E mutations and associated ultrasonic features. Correlation analysis, as well as univariate and multivariate logistic regression analysis, were conducted to identify independent risk factors for BRAFV600E mutation. The results were verified using a nomogram model.

Results:

The analysis results indicate that the BRAFV600E mutation correlates with tumor size, nodule size, taller-than-wide shape, margin, and shape of papillary thyroid cancer. The receiver operating characteristic curve was used to analyze the diagnostic effect of these features on BRAFV600E mutation. The results showed that nodule size had the most significant area under the curve (AUC = 0.665). Univariate and multivariate logistic regression analyses revealed that taller-than-wide shape ≥1, ill-defined margin, irregular shape, nodule size (≤1.40 cm), TT4 (>98.67 nmol/L), and FT3 (<4.14 pmol/L) were independent risk factors for BRAFV600E mutation. While considering all these factors in the nomogram, the Concordance index (C-index) remained high at 0.764. This suggests that the model has a good predictive effect.

Conclusion:

Ultrasound features including nodule size, taller-than-wide shape ≥1, ill-defined margins, irregular shape, higher TT4 levels, and lower FT3 levels were associated with papillary thyroid cancer aggressiveness and BRAFV600E mutation.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China